Skip to content

Dignostic value of novel biological markers for active pulmonary tuberculosis

Dignostic value of novel biological markers for active pulmonary tuberculosis: a single center, prospective, diagnostic study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036253
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis

Interventions

Gold Standard:Gole criteria: culture
CRS as clincial reference criteria
Index test:BATF2,&#32
UBE2L6,&#32
SERPING1,&#32
VAMP5

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 500 cases of adults more than 18 years old with 100 cases of healthy controls, agree to join the study.

Exclusion criteria

Exclusion criteria: Participants with serum postive, pregnant, and taking immunosuppressive agents.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;PPV;NPV;

Countries

China

Contacts

Public ContactFan Lin

Shanghai Pulmonary Hospital

fanlinsj@163.com+86 13918569516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026